logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Dirk Jan A. R. Moes

Department of Clinical Pharmacy and Toxicology
H指数:31
被引数:4,077

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness

修正：基于模型的其他给药策略用于皮下注射纳武利尤单抗以提高成本效益

Clinical Pharmacokinetics
IF4
2026-05-190
OAAI
Yan Wang; Laura H. Bukkems; Rob ter Heine; J. G. C. van Hasselt; S. L. W. Koolen; J. J. M. A. Hendrikx; Tom Van der Hulle; Ellen Kapiteijn; Juliette Zwaveling; Annemarie Becker; Michel M. van den Heuvel; Willemijn S. M. E. Theelen; Thijs H. Oude Munnink; Egbert F. Smit; Henk-Jan Guchelaar; Dirk Jan A. R. Moes
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic–Pharmacoeconomic Evaluation

基于治疗药物监测的度鲁特玛在肺癌患者中的个体化给药：一项全面的群体药代动力学–药效经济学评估

Clinical Pharmacokinetics
IF4
2025-07-250
OAAI
Fenna de Vries; Eric J. F. Franssen; Arthur A. J. Smit; Dirk Jan A. R. Moes; Anthonie J. van der Wekken; Thijs Oude Munnink; Jeroen J. M. A. Hendrikx; Daphne W. Dumoulin; Stijn L. W. Koolen; Wietske Kievit; Michel M. van den Heuvel; Rob ter Heine
A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients

一种用于指导活体和 deceased donor 肾移植受者他克莫司起始剂量和随访剂量的群体药代动力学模型和给药方案

Clinical Pharmacokinetics
IF4
2025-06-300
OA
Marith I. Francke; Sebastiaan D. T. Sassen; Nuria Lloberas; Helena Colom; Laure Elens; Serge Moudio; Aiko P. J. de Vries; Dirk Jan A. R. Moes; Ron H. N. van Schaik; Dennis A. Hesselink; Brenda C. M. de Winter
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study
BRITISH JOURNAL OF CANCER
IF6.8
2024-07-061
OA
van der Kleij, Maud B. A.; Guchelaar, Niels A. D.; Meertens, Marinda; Westerdijk, Kim; Giraud, Eline L.; Bleckman, Roos F.; Groenland, Stefanie L.; van Eerden, Ruben A. G.; Imholz, Alex L. T.; Vulink, Annelie J. E.; Otten, Hans-Martin; Fiebrich-Westra, Helle-Brit; Lubberman, Floor J. E.; Desar, Ingrid M. E.; Moes, Dirk-Jan A. R.; Touw, Daan J.; Koolen, Stijn L. W.; Gelderblom, Hans; Reyners, An K. L.; van Erp, Nielka P.; Mathijssen, Ron H. J.; Huitema, Alwin D. R.; Steeghs, Neeltje
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2024-06-300
OAAI
Borgers, Jessica S. W.; van Wesemael, Tineke J.; Gelderman, Kyra A.; Rispens, Theo; Verdegaal, Els M. E.; Moes, Dirk J. A. R.; Korse, Catharina M.; Kapiteijn, Ellen; Welters, Marij J. P.; van der Burg, Sjoerd H.; van Houdt, Winan J.; van Thienen, Johannes, V; Haanen, John B. A. G.; van der Woude, Diane

研究方向

暂未获取到该数据
H
Henk‐Jan Guchelaar
H 指数:79论文数:718被引数:2.6万
J
Johan W. de Fijter
H 指数:68论文数:489被引数:1.6万
J
Jesse J. Swen
H 指数:49论文数:257被引数:1.0万
A
Aiko P. J. de Vries
H 指数:44论文数:243被引数:9,477
T
Teun van Gelder
H 指数:79论文数:691被引数:2.1万
S
Soufian Meziyerh
H 指数:11论文数:44被引数:865
H
Hans Gelderblom
H 指数:107论文数:1,322被引数:5.3万
N
Nielka P. van Erp
H 指数:34论文数:281被引数:4,042
T
Tom C. Zwart
H 指数:10论文数:18被引数:663
P
Paul J. M. van der Boog
H 指数:31论文数:92被引数:2,560